Total Funding
47
Total FundingSeries E raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
22157
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
Aetna Wun Trombley: Board DirectorPast Role: NGM Biopharmaceuticals, President and Chief Operating Officer
James D. Watson: Chief Business OfficerPast Role: Alvine Pharmaceuticals, Chief Business Officer
About the Company
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, chemotype evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies.
